VectivBio Holding AG
VECTNASDAQHealthcare
$16.87
+$0.02(+0.12%)
Market Cap$1.1B
P/E Ratio—
52W High$16.98
52W Low$4.25
VectivBio Holding AG（VECT）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · VECT · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | ($93.73M) | ($87.01M) | ($59.94M) | ($23.48M) |
| Depreciation & Amort. | $0.24M | $0.30M | $0.27M | $0.15M |
| Stock-Based Comp. | $16.77M | $24.90M | $5.45M | $2.08M |
| Change in Working Capital | $9.50M | $1.19M | $2.40M | $4.97M |
| Net Cash from Operations | ($56.26M) | ($72.14M) | ($38.21M) | ($14.90M) |
| Investing Activities | ||||
| Capital Expenditure | ($0.07M) | ($0.06M) | ($0.09M) | ($0.06M) |
| Purchases of Investments | $0.00M | $0.00M | ($0.01M) | ($0.00M) |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | ($0.07M) | ($6.67M) | ($0.07M) | ($0.04M) |
| Financing Activities | ||||
| Common Stock Repurchased | ($0.01M) | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Financing | $175.06M | $141.33M | $56.59M | $32.81M |
| Free Cash Flow | ||||
| Free Cash Flow | ($56.33M) | ($72.20M) | ($38.30M) | ($14.95M) |
| FCF Margin %(computed) | -206.04% | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · M
深入了解VectivBio Holding AG
关于VectivBio Holding AG（VECT）现金流量表
VectivBio Holding AG 2022财年经营活动现金流($0.06B)，自由现金流($0.06B)（FCF利润率-206.04%），资本支出($0.00B)。
常见问题
VECT · 4 问VectivBio Holding AG 2022财年自由现金流($0.06B)，同比up22.0%。
VECT free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10